Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals

Cosman, F., Libanati, C., Deignan, C., Yu, Z., Wang, Z., Ferrari, S., Beck Jensen, J., Peris, P., Bertoldo, F., Lespessailles, E., Hesse, E., & Cummings, S. R. (2021). Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals. JBMR Plus, 5(11). Portico. https://doi.org/10.1002/jbm4.10546
Authors:
Felicia Cosman
Cesar Libanati
Cynthia Deignan
Zhigang Yu
Zhenxun Wang
Serge Ferrari
Jens-Erik Beck Jensen
Pilar Peris
Francesco Bertoldo
Eric Lespessailles
Eric Hesse
Steven R. Cummings
Affiliated Authors:
Felicia Cosman
Columbia Affiliation:
Author Keywords:
anabolics
antiresorptives
clinical trials
dxa
osteoporosis
elink
Publication Type:
Article
Unique ID:
10.1002/jbm4.10546
PMID:
34761149
DOI:
10.1002/jbm4.10546
Journal:
JBMR Plus
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: